Pfizer Seeks Dismissal Of Another Bextra Suit

Law360, New York (September 10, 2007, 12:00 AM EDT) -- Weeks after a federal court threw out nine cases targeting Pfizer Inc., the pharmaceutical giant is trying to poke holes through another amended complaint filed against it in the multidistrict litigation over its controversial anti-inflammatory drugs Bextra and Celebrex.

Pfizer, along with defendants Pharmacia Corp. and G.D. Searle LLC, asked the U.S. District Court for the Northern District of California on Monday to dismiss the amended complaint, in which a plaintiff allegedly suffered multiple heart attacks as a result of taking Bextra.

Pfizer claimed that the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.